Articles
Bottlenecks in vaccine development: Eliminate from the beginning
Promising vaccine candidates, rising global demand and preparations for the next pandemic influenza have brought vaccine’s role into focus in the past years and resulted in an impressive Pharma market share and revenue (US$ 26billion) in 2009. This...
Drug Research
New technique to speed up drug development
Scientists working at the European Molecular Biology Laboratory in Grenoble, France have developed a new technique that enables them to introduce up to 15 fluorescent markers to a mammalian cell in one go. They say their findings could help...
Drug Research
Optimer Pharmaceuticals Completes New Drug Application for Fidaxomicin
Optimer Pharmaceuticals, Inc.announced that it has completed the submission of its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for fidaxomicin to treat patients with Clostridium difficile infection (CDI) and to prevent recurrences of CDI....
Drug Research
New data show potential for Novartis Meningitis B vaccine
New data demonstrated that antibodies induced by Novartis Vaccines investigational, four component, Meningococcal Serogroup B Vaccine (4CMenB) killed the majority of a collection of geographically and genetically diverse meningococcal serogroup B (MenB) strains. The strain coverage research findings were...
Drug Research
Prolia(TM) (denosumab) Receives Best New Drug Honor at Scrip Awards
Amgen announced that it has won the Best New Drug awardfor Prolia(TM) (denosumab), a novel treatment approved in the United States (U.S.) for women with postmenopausal osteoporosis at high risk for fracture, at the2010 Scrip Awards...
Drug Research
Helix BioPharma Corp. completes Definative GLP toxicology studies with L-DOS47
Helix BioPharma Corp. announced that it has completed its definitive GLP, rodent and primate, repeat-dose toxicology studies with L-DOS47. These studies demonstrated a good safety profile in an expanded number of rodent and primate test animals, building upon Helix’s...
Drug Research
B. Braun Cefepime Now Available in Duplex drug delivery system
B. Braun, In an effort to meet industry demands for expanded Cephalosporin offerings delivered to patients through safe and accurate administration, B. Braun Medical Inc. (B. Braun) announced that FDA-approved 1g and 2g Cefepime for Injection USP and Dextrose...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
